In collaboration with West Yorkshire Integrated Care Board (WYICB), CDRC has developed a comprehensive suite of reports to identify patients living with diabetes (all types) who may or may not be using specific diabetes medical-technology ((continuous glucose monitors (CGM), insulin pumps, hybrid closed loop (HCL) systems)). These reports can be used:
- To identify and prioritise the people most likely to benefit from diabetes med-tech to optimise their diabetes management at practice/PCN/sub-ICB and ICB level,
- As a population health management tool to monitor diabetes med-tech activity in line with national and local implementation plans and
- To support equity of access to diabetes med-technology.
Accessing the CDRC reports on EMIS
To access the CDRC Diabetes Technology Population Reporting Searches on EMIS, you will need to download and import the following .zip file:
As the operator of the CDRC, Health Innovation North East and North Cumbria Limited (on behalf of itself and/or its licensors) grants you a licence to copy and download this document in accordance with our terms of use. You must not modify the content of this document in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text. For further details, please see our terms of use (Terms of use – Clinical Digital Resource Collaborative (cdrc.nhs.uk)
If you have not performed this process before, please refer to the Download/ Import guide below, which provides you with step-by-step instructions on how to Download and Import .zip files into EMIS:
*NB: this guide uses a Lipid Resource File for illustrative purposes only, the steps undertaken to import the CDRC Quality Diabetes IGR file are the same.
You can check whether you have the most up-to-date version by reviewing the date on the .zip file. Any updates to the Population Reporting searches will be communicated to CDRC Precision users via the mailing list for the CDRC. To ensure you stay up to date with the latest information, please sign up to the mailing list at http://eepurl.com/9131L
Guidance on the CDRC Diabetes Technology Reports
The reports are located in the CDRC Diabetes Technology > Diabetes Technology Focused Reports folder:

As you can see, there is a considerable number of reports in this folder. These reports have been grouped into the specific Diabetes Technologies for those coded with Type 1 and Type 2 / Other Diabetes in the clinical system. For each Diabetes Technology and Diabetes type, the reports are broken down further to highlight specific diabetes characteristics and demographic information, such as HbA1c level, number of Test Strip Prescriptions and Appointments; Ethnicity and Deprivation.
Population Health Data Analysis
To run all the reports in the Diabetes Technology folder, right-click on the ” Diabetes Technology Focused Reports ” and select ‘Run‘.
This process may take a few minutes.

Once the reports have been run, highlight the Diabetes Technology Focused Reports and click View Results in the ribbon:

To export the results, select Export which will open the Export Report menu:

Select CSV and save the file to an appropriate place on your computer; You will now be able to edit the report within Excel.
Data Quality & Coding Improvements
WYICB worked with NHSE to get the following SNOMED codes added to the CT library – these codes are intended to support improved coding of diabetes technology in clinical records, inform diabetes clinical care and monitoring of diabetes med-tech access. Improved coding of diabetes med-technology use has the potential to support research and evaluation into the impact of diabetes med-technology on clinical outcomes and wellbeing in people living with diabetes.
The following codes should be used to improve med-technology coding accuracy, clinical safety associated with med-technology and ultimately the clinical care of your patients:
- 1464561000000107 : Provision of continuous glucose monitoring system
- 1464641000000105 : Continuous glucose monitoring stopped
- 2242591000000104 : Provision of continuous subcutaneous insulin pump
- 2242611000000107 : Automated delivery of insulin using continuous subcutaneous insulin pump stopped
- 2242601000000105 : Provision of hybrid closed loop continuous automated insulin delivery system
- 2242621000000101 : Automated delivery of insulin using hybrid closed loop system stopped
National Diabetes Audit (NDA) 2024-25 quarterly report for England
The NDA have released their quarterly report and there is a slight difference in the methods used by the NDA and CDRC to identify patients with Type 2 Diabetes using CGM.
NDA Type 2 diabetes/Other:
- For those with type 2 diabetes, those who have any short acting insulin prescription who are recorded as on CGM over a 12 month reporting period are counted
CDRC:
- For those with type 2 diabetes, those with any insulin drug on repeat or have a current insulin pump code who are recorded as on CGM are counted.
NDA Type 1 diabetes:
- The NDA type 1 diabetes on CGM denominator is unrestricted and insulin type is not considered.
The restriction of the NDA data set for CGM coverage in the type 1 diabetes population is that is only includes CGM that has been prescribed via FP10, not other CGM types accessed most often only via specialist diabetes services in secondary care.
The new SNOMED codes above have the potential to improve coding of med-technology use in the type 1 diabetes population within a person’s SystmOne electronic clinical record.
A link to the NDA report can be found here: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/core-q4-24-25/national-diabetes-audit-nda-2024-25-quarterly-report-for-england-integrated-care-board-icb-primary-care-network-pcn-and-gp-practice(Edit)
